Modulation of asthmatic response by immunostimulatory DNA sequences.
Broide
D
D
Department of Medicine, University of California San Diego, La Jolla 92093-0635, USA.
Cho
J Y
JY
Miller
M
M
Nayar
J
J
Stachnick
G
G
Castaneda
D
D
Roman
M
M
Raz
E
E
D000276:Adjuvants, Immunologic / Q000494:pharmacology / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000494:pharmacology / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001249:Asthma / Q000150:complications / Q000276:immunology / Q000628:therapy*; D018899:CpG Islands; D004247:DNA / Q000494:pharmacology / Q000627:therapeutic use*; D016373:DNA, Antisense / Q000627:therapeutic use; D004269:DNA, Bacterial / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use; D004274:DNA, Recombinant / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use; D004802:Eosinophilia / Q000209:etiology / Q000276:immunology / Q000628:therapy; D004804:Eosinophils / Q000276:immunology; D015316:Genetic Therapy; D006801:Humans; D007114:Immunization; D009838:Oligodeoxyribonucleotides / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use; D010957:Plasmids / Q000235:genetics / Q000627:therapeutic use; D018418:Th2 Cells / Q000276:immunology; D019444:Vaccines, DNA / Q000627:therapeutic use; D014614:Vaccines, Synthetic / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D016373:DNA, Antisense; D004269:DNA, Bacterial; D004274:DNA, Recombinant; D009838:Oligodeoxyribonucleotides; D019444:Vaccines, DNA; D014614:Vaccines, Synthetic; D004247:DNA